WallStreetZenWallStreetZen

NASDAQ: HRTX
Heron Therapeutics Inc Stock Ownership - Who owns Heron Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Heron Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark Earl HensleyCOO2026-08-068,888$0.50
$4.44kSell
William P. ForbesEVP;CXO2026-07-313,326$0.50
$1.66kSell
Ira DuarteCFO;EVP2026-07-313,326$0.50
$1.66kSell
William P. ForbesEVP;CXO2026-07-303,348$0.50
$1.67kSell
Ira DuarteCFO;EVP2026-07-303,850$0.50
$1.93kSell
William P. ForbesEVP;CXO2026-07-191,101$0.47
$517.47Sell
Ira DuarteCFO;EVP2026-07-191,101$0.47
$517.47Sell
Ira DuarteEVP Chief Financial Officer2026-06-163,555$0.38
$1.35kSell

1 of 1

HRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HRTX insiders and whales buy or sell their stock.

HRTX Shareholders

What type of owners hold Heron Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Spch LLC20.11%38,174,476$13.59MInsider
Rubric Capital Management LP15.83%30,046,828$10.70MInsider
Perceptive Advisors LLC14.05%26,666,667$9.49MInsider
Adam Morgan4.68%8,877,027$3.16MInsider
Baker Brothers Life Sciences Capital GP LLC2.77%5,266,568$1.87MInsider
Velan Capital Investment Management LP2.37%4,500,000$1.60MInsider
Kevin C. Tang2.11%4,014,771$1.43MInsider
Savitr Capital LLC0.90%1,712,366$609.60kInsider
Baker Biotech Capital GP LLC0.75%1,432,692$510.04kInsider
Craig A. Collard0.45%856,492$304.91kInsider

1 of 3

HRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HRTX0.07%66.04%Net SellingNet Selling
NMAD0.01%40.53%
GOSS1.04%98.96%
XBIT0.01%46.67%
GUTS0.04%18.42%Net BuyingNet Buying
View Top Biotech Stocks

Heron Therapeutics Stock Ownership FAQ

Who owns Heron Therapeutics?

Heron Therapeutics (NASDAQ: HRTX) is owned by 0.07% institutional shareholders, 66.04% Heron Therapeutics insiders, and 33.89% retail investors. Spch LLC is the largest individual Heron Therapeutics shareholder, owning 38.17M shares representing 20.11% of the company. Spch LLC's Heron Therapeutics shares are currently valued at $13.28M.

If you're new to stock investing, here's how to buy Heron Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.